Sharemaestro Newsreel

Merit Medical reports $418.8M revenue and 9% organic growth

Merit Medical (NASDAQ: MMSI) reported strong second-quarter 2026 financial results, with revenue up 10% to $418.8 million and organic growth of 9%. The company also raised its full-year 2026 revenue guidance to $1.631–$1.643 billion and non-GAAP EPS guidance to $4.25–$4.35, reflecting confidence in continued …

Repligen (RGEN) Stock Faces A Margin Puzzle After Revenue Growth

Repligen (RGEN) recently reported Q2 2026 earnings with revenue growth and expanded adjusted gross and operating margins, despite a slip in net income. The article discusses the bull and bear cases for the stock, focusing on the company's shift towards recurring revenue and its …

Utah Medical's Q2 Earnings Down Y/Y Due to Customer Losses

Utah Medical Products, Inc. (UTMD) reported a significant year-over-year decline in Q2 2026 earnings and revenue, primarily due to the loss of two major customers. Diluted EPS decreased by 10.1% and revenues fell by 14.3%, although the company maintained solid profitability with resilient margins …

Avantor Stock Surged Because One Segment Stopped Shrinking

Avantor (AVTR) stock surged 15.8% after its June quarter results, driven by its VWR distribution segment returning to organic growth, despite overall organic revenue still contracting slightly. The company raised its 2026 organic revenue and adjusted earnings guidance. However, the smaller bioscience and medtech …

Why Are Baxter (BAX) Shares Soaring Today

Shares of Baxter International (BAX) jumped 8.7% after the company reported second-quarter results that surpassed analyst expectations for both revenue and earnings per share. The company also raised its full-year financial forecast, highlighting strong operational performance. This positive news comes shortly after TD Cowen …

HSBC Downgrades Intuitive Surgical to Hold From Buy, Adjusts Price Target to $391 From $604

HSBC has downgraded Intuitive Surgical (ISRG) from a Buy to a Hold rating. Concurrently, the firm significantly reduced its price target for ISRG to $391 from the previous $604. This adjustment reflects a more cautious outlook on the company's stock.

Warby Parker Inc. (WRBY) Reports Next Week: Wall Street Expects Earnings Growth

Becton Dickinson & Co. stock underperforms Thursday when compared to competitors

Becton Dickinson & Co. (BDX) stock fell 1.75% on Thursday, closing at $165.45, despite an overall positive trading session for the broader market. This drop snapped a four-day winning streak for the company's shares. The S&P 500 Index and Dow Jones Industrial Average both …

3 Promising Penny Stocks With Market Caps Up To $200M

This article identifies three promising penny stocks with market caps up to $200 million: KORU Medical Systems (KRMD), Planet Image International (YIBO), and Zevia PBC (ZVIA). Despite a recent drop in the U.S. market, these companies exhibit potential for growth, robust financial health, and …

Baxter Turnaround Efforts Continue Under New Management Team

Baxter International (BAX) is undergoing a turnaround under new management, following challenges in 2022-2023. Despite a successful Baxalta spinoff in 2015, the company faced financial difficulties exacerbated by the Hillrom acquisition, inflation, and weak medical utilization. However, with elevated medical utilization, easing supply chain …

BAX Stock Gains on Q2 Earnings & Sales Beat, Margins Contract

Baxter International Inc. BAX reported second-quarter 2026 adjusted earnings per share (EPS) from continuing operations of 56 cents, which topped the Zacks Consensus Estimate of 36 cents by 55.6%. The bottom line declined 5% from the year-ago quarter's level. On a GAAP basis, the …

Pulse Biosciences (PLSE.US) squeeze baby squeeze

The user "Papacito" posted a short message about Pulse Biosciences (PLSE.US), suggesting a potential "squeeze." The post was made in the moomoo Community, which offers educational content and discussions for investors. The article briefly mentions leading technology companies and their stock performance.

Baxter Jumps After Q2 Beat, Boosted 2026 Guidance Reflects Turnaround Progress

Baxter International (BAX) shares surged after the company announced better-than-expected Q2 financial results and raised its fiscal 2026 guidance. The hospital product maker reported adjusted earnings of 54 cents per share and sales of $2.96 billion, exceeding analyst consensus. This positive performance was primarily …

Nyxoah SA (NYXH) Share Price Quote Today & Current Price Chart

This article provides current share price information and trading conditions for Nyxoah SA (NYXH) as a CFD on Capital.com. It details financial figures like previous close, open, and day's range, alongside CFD trading specifics such as spreads, overnight funding adjustments, and margin requirements. The …

Baxter’s shares soar by 17% after reporting positive Q2

Baxter reported a 5% increase in Q2 revenues to $2.96bn, driven by strong performance in its medical products and therapies segment, which led to a 17% surge in its share price on the NYSE. The company raised its 2026 outlook for sales growth and …

Lucyd (Nasdaq:LUCY) - Stock Analysis

This Simply Wall St stock analysis provides an overview of Lucyd (Nasdaq: LUCY), a smart eyewear developer. It highlights key financial metrics, future growth potential, past performance, and identified risks such as share price volatility and dilution. The article also details recent company announcements, …

NXGL|Nexgel Inc|Price:0.415|Chg%:-0.029

This article provides a comprehensive stock analysis of Nexgel Inc (NXGL) from TradingKey, highlighting its stable fundamentals, high growth potential, and fair valuation within the Pharmaceuticals industry. The company's stock score details its financial health, institutional confidence, and an analyst rating of "Buy" with …

KORU Medical Systems, Inc. (NASDAQ:KRMD) Given Consensus Rating of "Moderate Buy" by Brokerages

KORU Medical Systems (NASDAQ:KRMD) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $7.25. Insiders have recently purchased shares worth approximately $109,430, and the stock traded up 0.9% to $4.11. The company develops and manufactures medical devices …

ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth

Wall Street anticipates earnings growth for ResMed (RMD) when it reports its results for the quarter ending June 2026, with analysts expecting a 13.7% year-over-year increase in earnings per share and an 8.4% rise in revenues. However, the Zacks Earnings ESP indicates a potential …

ALGN Q2 Earnings Call Highlights Digital Growth Push

Align Technology (ALGN) highlighted strong Invisalign growth and expanding digital workflows in its Q2 2026 earnings call, despite near-term pressures from scanner pricing changes. The company reported record clear aligner volumes and strategic investments to drive adoption, while also focusing on improving operating margins …

Wall Street Analysts Believe Repligen (RGEN) Could Rally 25.72%: Here's is How to Trade

Repligen (RGEN) closed the last trading session at $141.23, gaining 1.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of …

Baxter International stock hits 52-week high at 29.04 USD

Baxter International stock recently hit a 52-week high of $28.94 and is currently trading at $29.53, reflecting strong investor confidence and significant year-to-date returns. InvestingPro analysis indicates the stock may be slightly overvalued, though the company's recent Q2 earnings and revenue surpassed analyst expectations, …

Baxter (NYSE:BAX) Reports Upbeat Q2 CY2026, Stock Jumps 16.1%

Baxter International (NYSE:BAX) reported strong Q2 CY2026 results, surpassing analysts' revenue expectations with a 5.3% year-on-year sales increase to $2.96 billion and a non-GAAP profit significantly above consensus estimates. The healthcare company also raised its full-year Adjusted EPS guidance, leading to a 16.1% jump …

Deutsche Bank Adjusts Avantor Price Target to $13 From $11, Maintains Hold Rating

Deutsche Bank has updated its price target for Avantor (AVTR), increasing it to $13 from the previous $11, while keeping a "Hold" rating on the stock. This adjustment reflects a modest increase in the valuation outlook for the life sciences tools and services company. …

KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference

KORU Medical Systems, a leading medical technology company, announced its participation in the Canaccord Genuity 46th Annual Growth Conference. Management will present on August 12, 2026, at 10:00 am ET, and interested parties can access the webcast via the company's investor relations website. KORU …

Envista (NVST) Stock Jumps 5.2%: Will It Continue to Soar?

Envista (NVST) stock surged 5.2% to $28.37, driven by investor optimism ahead of its Q2 2026 earnings release on August 5th. The company anticipates a 4.8% year-over-year revenue increase and a 26.9% increase in earnings per share to 33 cents. Despite the positive outlook, …

Baxter International Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:BAX) 2026-07-30

Baxter International Inc. released its Q2 2026 earnings call presentation on July 30, 2026. The company reported an EPS of $0.56, beating estimates by $0.19, and revenue of $2.96 billion, exceeding expectations by $164.49 million with a 5.34% year-over-year increase. This article from SA …

Baxter raises annual profit forecast on strong demand for IV solutions

Medical products maker Baxter International has raised its annual profit forecast and exceeded Wall Street's quarterly estimates, driven by strong sales of IV solutions and other medical products. The company's shares jumped 14% premarket, despite ongoing challenges with its Novum infusion pump shipments. Baxter …

Repligen (NASDAQ:RGEN) Combines Strong Growth with a Promising Technical Breakout Setup

Repligen (NASDAQ:RGEN) is highlighted as a compelling stock due to its strong fundamental growth, including significant revenue and EPS increases, combined with a promising technical breakout setup. The company shows an impressive growth rating with accelerating EPS expectations, despite an elevated valuation. Technically, RGEN …

Are Options Traders Betting on a Big Move in AtriCure Stock?

Options traders are showing significant interest in AtriCure (ATRC) stock, with the Sep 18, 2026 $50 Call exhibiting high implied volatility, suggesting expectations of a large price movement. Despite this, analysts currently rate AtriCure as a Zacks Rank #3 (Hold), and recent earnings estimates …

Dentsply Sirona Number of Employees 2026 | Employee Count & Headcount Data

Dentsply Sirona (NASDAQ: XRAY) had approximately 13,897 employees worldwide as of March 2026, representing a 4.7% decline since 2023. The company is actively hiring with 802 job postings in 2026, though new postings per month have decreased. The workforce is concentrated in North America, …

Harvard Bioscience Inc (HBIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Harvard Bioscience Inc (HBIO), detailing its current price momentum score, support and resistance levels, and various technical indicators. It presents a summary of buy, sell, and neutral signals based on indicators like MACD, RSI, and moving averages, …

Stevanato’s Alina pen injector gains EU approval for liraglutide

Stevanato Group S.p.A. announced that its Alina pen injector platform has received marketing authorizations in Europe for liraglutide-based combination products. The approval covers Alina 30 for diabetes therapies and Alina 50 for weight management. The Alina platform is a variable-dose, disposable pen injector designed …

Baxter stock surges 13% on earnings and revenue beats

Baxter International Inc. (NYSE:BAX) reported Q2 results that exceeded analyst expectations, leading to a 12.84% surge in its stock. The company's adjusted EPS and revenue surpassed estimates, attributed partly to an unexpected tariff refund. Baxter also raised its full-year 2026 financial outlook for both …

Why is Align Technology stock sliding today?

Align Technology's stock is sliding due to a lower-than-expected revenue outlook for Q3 2026, overshadowing otherwise solid Q2 results. The company also faces challenges in its Systems and Services revenue, a significant UK VAT liability, and upcoming restructuring costs, although it did increase its …

Baxter Reports Second-Quarter 2026 Results

Second-quarter sales of $2.96 billion increased 5% on both a reported and organic basis,1, 2 reflecting growth in all segments and divisions Second-quarter U.S. GAAP3 diluted earnings per share (EPS) of $0.26; adjusted diluted EPS of $0.56 Company raises full-year 2026 financial outlook DEERFIELD, …